Introduction
FDG PET-CT (Fluorodeoxyglucose Positron Emission Tomography – Computed Tomography) is an advanced diagnostic imaging test widely used in oncology to detect, stage, and monitor cancer.
It combines functional imaging that shows metabolic activity with detailed anatomical CT images, allowing accurate localization of active disease.
FDG is a glucose-based radiotracer that accumulates in tissues with high metabolic activity, such as many types of cancer cells.
By identifying areas of increased FDG uptake, PET-CT helps physicians distinguish active disease from inactive tissue, scar, or post-treatment changes.
Türkiye is a trusted destination for advanced nuclear medicine imaging, offering modern FDG PET-CT technology, experienced specialists, and integrated oncology care.
Averia Health supports international patients through ethical, structured, and fully coordinated FDG PET-CT services focused on accuracy, safety, and clinical clarity.
Why Choose Türkiye for FDG PET-CT
Türkiye is internationally recognized for high-quality FDG PET-CT imaging because of:
- Advanced PET-CT scanners with high image resolution
- Experienced nuclear medicine physicians and radiologists
- Strict radiation safety and quality control protocols
- Multidisciplinary collaboration with oncology teams
- Modern, internationally accredited hospitals
Türkiye combines advanced technology with reliable diagnostic expertise.
Why Choose Averia Health
Averia Health provides comprehensive coordination for FDG PET-CT scans:
- Pre-arrival review of medical history and imaging indication
- Referral to accredited nuclear medicine centers
- Clear explanation of preparation and procedure steps
- Coordination with oncology, surgery, or radiation therapy teams
- Professional interpreter services
- 24/7 patient support during your visit
- Timely reporting and international follow-up coordination
Our approach prioritizes diagnostic precision, transparency, and patient reassurance.
Conditions Evaluated with FDG PET-CT
FDG PET-CT is commonly used for:
- Initial cancer detection and staging
- Evaluation of lymph node and distant metastases
- Monitoring response to chemotherapy, radiotherapy, or immunotherapy
- Detection of cancer recurrence
- Assessment of lymphoma, lung cancer, colorectal cancer, breast cancer, head and neck cancers, melanoma, and many other malignancies
- Selected inflammatory or infectious conditions
The indication for FDG PET-CT is determined by the treating physician based on clinical needs.
Types of FDG PET-CT Applications
Cancer Staging
Determines the extent of disease and guides treatment planning.
Treatment Response Assessment
Evaluates how effectively therapy is controlling active disease.
Recurrence Detection
Identifies metabolically active recurrent tumors before structural changes appear.
Whole-Body Disease Evaluation
Assesses multiple organs in a single examination.
Diagnostic Evaluation Before FDG PET-CT
Preparation and evaluation may include:
- Review of prior imaging studies (CT, MRI, ultrasound)
- Fasting for several hours before the scan
- Blood glucose measurement prior to tracer injection
- Review of medications and medical history
- Pregnancy or breastfeeding assessment when applicable
Proper preparation is essential for accurate FDG uptake and reliable results.
FDG PET-CT Scan Journey in Türkiye
- Pre-Arrival Case Review
Medical records and imaging indications are reviewed in advance. - Nuclear Medicine Consultation
The procedure, preparation, and safety measures are explained clearly. - FDG Tracer Administration
A small, medically safe amount of FDG is administered intravenously. - PET-CT Imaging
Whole-body imaging is performed using advanced hybrid PET-CT scanners. - Image Interpretation
Findings are analyzed by experienced nuclear medicine specialists. - Results & Care Coordination
Results are shared with your treating physician, and next steps are coordinated.
Expected Results & Benefits
- Accurate detection of metabolically active disease
- Precise cancer staging
- Improved treatment planning
- Early assessment of treatment effectiveness
- Reduced need for unnecessary procedures
FDG PET-CT plays a central role in modern oncologic decision-making.
Risks & Considerations
FDG PET-CT is safe and well established. Considerations include:
- Exposure to a low level of radiation
- Temporary discomfort from injection
- Need to follow fasting and preparation instructions
Radiation exposure is minimized and justified by its diagnostic benefit.
What’s Included in Your Medical Visit
- FDG PET-CT scan appointment
- Nuclear medicine consultation
- FDG tracer administration
- PET-CT imaging and expert interpretation
- Written diagnostic report
- Coordination with oncology or referring physicians
- Interpreter services
- Patient support and follow-up coordination
Averia Health ensures ethical, precise, and patient-centered diagnostic imaging care.
Frequently Asked Questions
Is FDG PET-CT painful?
No. The scan is non-invasive and generally well tolerated.
How long does the FDG PET-CT process take?
The full visit usually takes a few hours, including preparation and imaging.
Is FDG PET-CT safe?
Yes. Radiation exposure is carefully controlled within medical guidelines.
Can FDG PET-CT detect all cancers?
It is highly effective for many cancers, though suitability depends on tumor type.
How quickly will I receive the results?
Results are typically available shortly after image interpretation.
Ready to Start Your Health Journey?
Obtain accurate, advanced oncologic imaging with FDG PET-CT in Türkiye.
Request a case review or contact us on WhatsApp to speak with our diagnostic care coordination team.
